These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31760648)

  • 81. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Remyelination in multiple sclerosis.
    Lassmann H; Brück W; Lucchinetti C; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic analysis of CNS remyelination.
    Bieber AJ
    Curr Top Microbiol Immunol; 2008; 318():177-92. PubMed ID: 18219818
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tumefactive demyelinating lesions: A comprehensive review.
    Algahtani H; Shirah B; Alassiri A
    Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
    Kim MJ; Kang JH; Theotokis P; Grigoriadis N; Petratos S
    Cells; 2018 Dec; 8(1):. PubMed ID: 30577457
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Multiple sclerosis: remyelination in acute lesions.
    Raine CS; Wu E
    J Neuropathol Exp Neurol; 1993 May; 52(3):199-204. PubMed ID: 7684075
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
    Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination.
    Trebst C; Heine S; Lienenklaus S; Lindner M; Baumgärtner W; Weiss S; Stangel M
    Acta Neuropathol; 2007 Dec; 114(6):587-96. PubMed ID: 17940777
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.
    Silvestroff L; Bartucci S; Pasquini J; Franco P
    Exp Neurol; 2012 May; 235(1):357-67. PubMed ID: 22421533
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
    Tobin WO; Popescu BF; Lowe V; Pirko I; Parisi JE; Kantarci K; Fields JA; Bruns MB; Boeve BF; Lucchinetti CF
    Mult Scler; 2016 Apr; 22(5):698-704. PubMed ID: 26447065
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.
    Harrer MD; von Büdingen HC; Stoppini L; Alliod C; Pouly S; Fischer K; Goebels N
    Exp Neurol; 2009 Apr; 216(2):431-8. PubMed ID: 19320002
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Promoting myelin repair in disorders such as multiple sclerosis and some types of leukodystrophy: current studies].
    Baron-Van Evercooren A; Lachapelle F; Nait-Oumesmar B; Pham-Dinh D
    Rev Neurol (Paris); 2007 May; 163(5):523-31. PubMed ID: 17571021
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis.
    Bö L; Geurts JJ; Ravid R; Barkhof F
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):106-17. PubMed ID: 15043708
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.
    Yao Y; Nguyen TD; Pandya S; Zhang Y; Hurtado Rúa S; Kovanlikaya I; Kuceyeski A; Liu Z; Wang Y; Gauthier SA
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):303-310. PubMed ID: 29242359
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multiple Sclerosis Part 1: Essentials and the McDonald Criteria.
    Gill S; Agarwal M
    Magn Reson Imaging Clin N Am; 2024 May; 32(2):207-220. PubMed ID: 38555137
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Honing in on magnetic resonance imaging predictors of multiple sclerosis pathology.
    Schmierer K
    Brain Pathol; 2023 Nov; 33(6):e13209. PubMed ID: 37646614
    [No Abstract]   [Full Text] [Related]  

  • 99. Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.
    Schmierer K; Parkes HG; So PW
    Neurology; 2009 Feb; 72(5):472. PubMed ID: 19188581
    [No Abstract]   [Full Text] [Related]  

  • 100. Remyelination in multiple sclerosis: from concept to clinical trials.
    Kremer D; Göttle P; Flores-Rivera J; Hartung HP; Küry P
    Curr Opin Neurol; 2019 Jun; 32(3):378-384. PubMed ID: 30865009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.